BSEAGM/EGM5d ago · 30 Jul 2026, 05:12 pm
Intimation of Book Closure and Cut-off Date for the AGM
Oxygenta Pharmaceutical Ltd · 524636
✦ AI Summary
Oxygenta Pharmaceutical Ltd has announced the book closure and cut-off date for its 33rd Annual General Meeting (AGM) to be held on August 21, 2026. The register of members and share transfer books will be closed from August 15 to 21, 2026, and the company has fixed August 14, 2026, as the cut-off date for remote e-voting.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment1/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Oxygenta Pharmaceutical Ltd - 524636 - Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.
Attachments (1)
📄pdf
Download →
232b00f6-393e-4e80-b11b-f61fb361f815.pdf
View document text
VIRUPAKSHA
Date: 30.07.2026
The Manager
BSE Limited
P.J. Towers, Dalal Street
Mumbai-400001
Dear Sir/ Madam,
Sub: Intimation of Book Closure and Cut-Off Date for the 33™ Annual General Meeting of
Oxygenta Pharmaceutical Limited
Ref: ISIN: INE102E01018
With reference to the subject cited, this is to inform that the Register of Members and the Share
transfer books of the Company will remain closed from 15% August, 2026 to 21* August, 2026 (both
days inclusive) for the purpose of 33 Annual General Meeting scheduled to be held on 21% August,
2026 at 10:30 a.m. through Video Conference / Other Audio-Visual Means.
Symbol / Stock Type of | Book Closure Record Purpose
Scrip Code | Exchange Security Date
524636 BSE Limited | Equity 15T August, 2026 to | - Annual General
Shares 21* August, 2026 Meeting
(both days inclusive)
‘We would further like to inform that the Company has fixed Friday, 14™ August, 2026 as cut-off date
for the purpose of remote e-voting, for ascertaining the names of the Shareholders holding shares
either in physical form or in dematerialized form, who will be entitled to cast their votes electronically
in respect of the businesses to be transacted at the Annual General Meeting.
You are requested to kindly take the same on record for your further needful.
Thanking You,
Yours faithfully,
For Oxygenta Pharmaceutical Limited
Balasubba Reddy Mamilla
Executive Director
(DIN: 01998852)
OXYGENTA PHARMACEUTICAL LIMITED (Subsidiary of VIRUPAKSHA ORGANICS LIMITED)
(An 1SO 9001:2015, ISO 14001:2018 and ISO 45001:2015 Certified Company)
Regd off.& Factory: Sy.No. 252/1, Aroor (V), Sadasivapet (M), Sangareddy (Dist)-502 291, Telangana, INDIA. Tel: 08455-250080
Corp. Office: Level-1, Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad — 500 037, Telangana, INDIA.
E-Mail id: info@oxygentapharma.com. Website: www.oxygentapharma.com,
Phone 040-23073417, CIN: L24110TG1990PLC012038